Calamos Advisors
IART icon

Calamos Advisors’s Integra LifeSciences IART Stock Holding History

Calamos Advisors’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$284K Buy
+30,171
New +$331K ﹤0.01% 1042

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Calamos Advisors's IART Position: Q1 2026 in Review

Calamos Advisors opened a new position in Integra LifeSciences (IART) in Q1 2026: 30,171 shares worth $284K. The stake represents ﹤0.01% of the portfolio and ranks #1042 among its holdings.

201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Calamos Advisors held 30,171 shares of Integra LifeSciences worth $284K as of Q1 2026.
  • Integra LifeSciences was a new Calamos Advisors position in Q1 2026.
  • Integra LifeSciences made up ﹤0.01% of Calamos Advisors's portfolio in Q1 2026, its #1042 holding.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Calamos Advisors's 13F filing for Q1 2026, filed 4 May 2026.